{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15810594", "DateCompleted": {"Year": "2005", "Month": "09", "Day": "02"}, "DateRevised": {"Year": "2006", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-4454", "JournalIssue": {"Volume": "27", "Issue": "11", "PubDate": {"Year": "2004", "Month": "Nov"}}, "Title": "Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials", "ISOAbbreviation": "Zhong Yao Cai"}, "ArticleTitle": "[Anti-tumor effects of ampelopsin on human lung cancer GLC-82 implanted in nude mice].", "Pagination": {"StartPage": "842", "EndPage": "845", "MedlinePgn": "842-5"}, "Abstract": {"AbstractText": ["To investigate the effects of ampelopsin on the growth of human lung cancer cell line GLC-82 in nude mice.", "GLC-82 cells were inoculated into the armpit of nude mice to establish lung cancer model. Then the BALB/C nude mice 6 with xenograft tumor were randomized into 6 groups. Ampelopsin was administered at 3 dosages by intraperitoneal injection daily. The anti-tumor effect of ampelopsin was evaluated on tumor volume, relative tumor volume, tumor weight, relative tumor proliferative rale, and tumor growth curve.", "At the 250 mg/kg dose of ampelopsin, the growth inhibition of the transplant tumor was 35.5% (P < 0.01) and 37.1% (P < 0.01), and the relative tumor proliferative rate was 55.24% (P < 0.01) and 57.71% (P < 0.05), respectively in two independent experiments by compared with the normal saline control.", "Ampelopsin appears to be a potent anti-tumor agent that was firstly discovered in the transplant human lung cancer cell line GLC-82 in nude mice in vivo."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of pharmaceutical Sciences, Sun Yat-sen University, Guangzhou."}], "Identifier": [], "LastName": "Zeng", "ForeName": "Sa", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Deyu", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ye", "ForeName": "Yanli", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Liangui", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Wei", "Initials": "W"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhong Yao Cai", "NlmUniqueID": "9426370", "ISSNLinking": "1001-4454"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "27200-12-0", "NameOfSubstance": "ampelopsin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": [], "DescriptorName": "Neoplasm Transplantation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "4", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "9", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "4", "Day": "7", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15810594"]}}], "PubmedBookArticle": []}